Organon (OGN) Change in Cash (2021 - 2026)

Organon (OGN) posted quarterly Change in Cash of $542.0 million for Q1 2026, up 523.44% year-over-year from $86.9 million in Q1 2025, and up 653.06% on a QoQ basis from -$98.0 million in Q4 2025.

Organon (OGN) Change in Cash (2021 - 2026) Analysis & Trends

Organon (OGN) has reported Change in Cash for 6 consecutive years, with $542.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Cash rose 523.44% year-over-year to $542.0 million; the TTM figure through Mar 2026 stood at $569.0 million (up 2132.14% YoY), while the FY2025 annual figure was -$101.0 million, down 461.11% from the prior year.
  • Change in Cash came in at $542.0 million for Q1 2026 at Organon, up from -$98.0 million in the prior quarter.
  • The five-year high for Change in Cash was $542.0 million in Q1 2026, with the low at -$247.0 million in Q1 2023.
  • Average Change in Cash over 5 years is $22.3 million, with a median of -$43.0 million recorded in 2022.
  • Across the five-year window, Change in Cash plunged 474.42% in 2023 and soared 523.44% in 2026, its largest moves.
  • Year by year, Change in Cash stood at $207.0 million in 2022, then soared by 34.78% to $279.0 million in 2023, then plunged by 131.54% to -$88.0 million in 2024, then retreated by 11.36% to -$98.0 million in 2025, then soared by 653.06% to $542.0 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered $542.0 million, -$98.0 million, and $73.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -1.99 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 1.98 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 4.16 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 5.70 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -9.29 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 65.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 563.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 542.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 542.00 Mn
Dec 31, 2025 -98.00 Mn
Sep 30, 2025 73.00 Mn
Jun 30, 2025 52.00 Mn
Mar 31, 2025 -128.00 Mn
Dec 31, 2024 -88.00 Mn
Sep 30, 2024 59.00 Mn
Jun 30, 2024 129.00 Mn
Mar 31, 2024 -118.00 Mn
Dec 31, 2023 279.00 Mn
Sep 30, 2023 88.00 Mn
Jun 30, 2023 -133.00 Mn
Mar 31, 2023 -247.00 Mn
Dec 31, 2022 207.00 Mn
Sep 30, 2022 -46.00 Mn
Jun 30, 2022 -149.00 Mn
Mar 31, 2022 -43.00 Mn
Dec 31, 2021 -271.00 Mn
Sep 30, 2021 278.00 Mn
Jun 30, 2021 569.00 Mn